Substance / Medication

Cyproheptadine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine.
Okuma Hirohisa, Iijima Kazuyuki, Yasuda Takashi et al. · Springerplus · 2013
PMID: 24255866Case ReportFull text (PMC)
Establishment of ultrasensitive immunoassay strip based on colloidal gold-McAb probe for detecting cyproheptadine hydrochloride and six phenothiazines in feed.
Hu Xiaofei, Na Guanqiong, Sun Yaning et al. · Food Addit Contam Part A Chem Anal Control Expo Risk Assess · 2023
PMID: 37819997Other
In Silico and In Vitro Studies of the Inhibitory Effect of Antihistamine Drug Cyproheptadine Hydrochloride on Human Salivary Alpha Amylase.
Madjda Benguechoua, Khedidja Benarous, Samira Nia et al. · Antiinflamm Antiallergy Agents Med Chem · 2021
PMID: 33100209Other
A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride.
Razzaghy-Azar Maryam, Nourbakhsh Mitra, Nourbakhsh Mona · Clin Endocrinol (Oxf) · 2018
PMID: 29520979Other
Cyproheptadine hydrochloride inhibits African swine fever viral replication in vitro.
Cui Huimei, Yang Jinke, Yang Bo et al. · Microb Pathog · 2023
PMID: 36572196Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cyproheptadine hydrochloride (substance)
SNOMED CT
15352003
UMLS CUI
C0354872

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

8
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.